Seminal transforming growth factor-beta in normal and infertile men.
Transforming growth factor-beta (TGFbeta) is a cytokine with autocrine and paracrine action in the testis and potent immunoregulatory and anti-inflammatory activities. In the present study, we examined the concentration of latent (acid-activatable) and free (active) TGFbeta in seminal plasma from normal subjects (n = 23) and infertile (n = 40) patients, by using a TGFbeta specific immunoenzymological assay, and a bioassay (CCL64 cell line growth inhibition) detecting any form of TGFbeta. Free TGFbeta1 was present in normal subjects at a concentration (1.82 +/- 1.06 ng/ml) close to that known to give maximal stimulation in vitro. In pathological groups, the mean concentrations were not significantly different from the normal ones. Latent TGFbeta1 was present in normal seminal plasma at a high concentration (92.4 +/- 29.2 ng/ml). In subjects with pathologies of both testis and genital apparatus, or with epididymal occlusion, mean latent TGFbeta1 concentrations were normal, whereas transferrin concentrations were lower. The concentrations found in the epididymal occlusion group indicate that TGFbeta1 is, for a large part, secreted by the genital tract. In the testicular pathology group, TGFbeta1 concentrations were 130.7 +/- 61.2 ng/ml, a mean not statistically different from normal, although higher. No differences were found between patients with high and normal blood plasma follicle stimulating hormone, and this is consistent with the notion that most TGFbeta1 in seminal plasma is not of testicular origin. The TGFbeta bioassay ensured that immunologically detected TGFbeta was present in a bioactive or bioactivatable form. Furthermore, the values found in normal and pathological seminal plasmas were usually higher than those detected by the immunoassay, suggesting that other forms of TGFbeta might be present. Together, the present data show that very large amounts of TGFbeta are present in human seminal plasma. The TGFbeta ligand assay in the seminal plasma appears to indicate no differences between normal and infertile subjects.
Loras
B
B
Institut National de la Santé et de la Recherche Médicale, INSERM U407, Faculté de Médecine Lyon-Sud, B.P. 12, F-69961 Oullins cedex, France.
Vételé
F
F
El Malki
A
A
Rollet
J
J
Soufir
J C
JC
Benahmed
M
M
D000818:Animals; D002455:Cell Division; D002460:Cell Line; D004822:Epididymis / Q000473:pathology; D004847:Epithelial Cells / Q000166:cytology; D005832:Genital Diseases, Male / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007124:Immunoenzyme Techniques; D007248:Infertility, Male / Q000378:metabolism*; D008168:Lung / Q000166:cytology; D008297:Male; D008907:Mink; D012661:Semen / Q000737:chemistry*; D013733:Testicular Diseases / Q000378:metabolism / Q000473:pathology; D014168:Transferrin / Q000032:analysis; D016212:Transforming Growth Factor beta / Q000032:analysis* / Q000494:pharmacology
D014168:Transferrin; D016212:Transforming Growth Factor beta